Clinical Trial Update: IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC [Phase 2]

View source ↗

Summary

This Phase II IMPAACT trial evaluated adjuvant pembrolizumab after IMRT in anaplastic thyroid carcinoma. The study was terminated, and results were posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Thyroid | Phase 2 | Status: TERMINATED | Results posted: 2026-03-23